Skip to content

Seres Therapeutics, Inc.: filings

Every Seres Therapeutics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 45 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-05fiscal Q2 2026421240001193125-26-334174
10-Q2026-05-05fiscal Q1 202642880001193125-26-205434
10-K2026-03-12fiscal FY 2025461210001193125-26-103276
10-Q2025-11-05fiscal Q3 2025461350001193125-25-266011
10-Q2025-08-06fiscal Q2 2025421220000950170-25-103611
10-Q2025-05-07fiscal Q1 202542870000950170-25-065173
10-K2025-03-13fiscal FY 2024421120000950170-25-038427
10-Q2024-11-13fiscal Q3 2024421260000950170-24-126018
10-Q2024-08-13fiscal Q2 2024461330000950170-24-095821
10-Q2024-05-08fiscal Q1 202445930000950170-24-055159
10-K2024-03-05fiscal FY 2023471230000950170-24-025464
10-Q2023-11-02fiscal Q3 2023461350000950170-23-057805
10-Q2023-08-08fiscal Q2 2023461330000950170-23-039439
10-Q2023-05-09fiscal Q1 202343890000950170-23-019222
10-K2023-03-07fiscal FY 2022471280000950170-23-006374
10-Q2022-11-02fiscal Q3 2022471450000950170-22-021018
10-Q2022-08-03fiscal Q2 2022451350000950170-22-014052
10-Q2022-05-04fiscal Q1 202244950000950170-22-007217
10-K2022-03-01fiscal FY 2021441110000950170-22-002435
10-Q2021-11-10fiscal Q3 2021461350000950170-21-003937
10-Q2021-08-03fiscal Q2 2021401100000950170-21-000674
10-Q2021-05-04fiscal Q1 202140810001564590-21-023017
10-K2021-03-02fiscal FY 2020431050001564590-21-010057
10-Q2020-11-09fiscal Q3 2020401110001564590-20-052273
10-Q2020-07-28fiscal Q2 2020401060001564590-20-033715
10-Q2020-05-07fiscal Q1 202039780001564590-20-022457
10-K2020-03-02fiscal FY 2019421220001564590-20-008002
10-Q2019-11-05fiscal Q3 2019401070001564590-19-040255
10-Q2019-08-06fiscal Q2 2019391020001564590-19-029069
10-Q2019-05-02fiscal Q1 201938740001564590-19-015070
10-K2019-03-06fiscal FY 2018361190001564590-19-006423
10-Q2018-11-08fiscal Q3 201833880001564590-18-028339
10-Q2018-08-02fiscal Q2 201834900001564590-18-018757
10-Q2018-05-09fiscal Q1 201829620001564590-18-012140
10-K2018-03-08fiscal FY 2017311000001564590-18-004830
10-Q2017-11-08fiscal Q3 201728780001564590-17-022569
10-Q2017-08-03fiscal Q2 201728780001564590-17-015366
10-Q2017-05-04fiscal Q1 201728580001564590-17-008791
10-K2017-03-16fiscal FY 201629970001564590-17-004551
10-Q2016-11-10fiscal Q3 201628730001564590-16-028938
10-Q2016-08-11fiscal Q2 201627720001564590-16-024023
10-Q2016-05-16fiscal Q1 201627550001564590-16-019550
10-K2016-03-14fiscal FY 201529960001564590-16-014692
10-Q2015-11-12fiscal Q3 201528760001564590-15-010634
10-Q2015-08-10fiscal Q2 201527750001193125-15-284924

Inspect the source

Entity
Seres Therapeutics, Inc. / CIK 0001609809
Captured
2026-09-20T09:26:38.649Z
SEC response SHA-256
105bfeb60dac37400daa54dfa3defd1c13ed7aa1d79341515907d114c9c517e6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001609809.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))